Combination of CCR1 mRNA, MCP1, and CA125 Measurements in Peripheral Blood as a Diagnostic Test for EndometriosisDepartment of Gynecology and Obstetrics, University of Schleswig-Holstein, Luebeck, Germany
Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Luebeck, Germany
Department of Gynecology and Obstetrics, Technical University of Aachen, Aachen, Germany
Praxisklinik für Fertilität, Am Gendarmenmarkt, Berlin, Germany
Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Luebeck, Germany
Department of Gynecology and Obstetrics, University of Schleswig-Holstein, Luebeck, Germany, d.hornung{at}gmx.de This study investigated the possible use of CCR1 mRNA measurement in peripheral blood leukocytes in combination with measurements of monocyte chemotactic protein-1 (MCP-1) and CA125 protein in serum as a diagnostic test for endometriosis.The expression of CCR1 mRNA in peripheral blood leukocytes was measured by quantitative real-time polymerase chain reaction. MCP-1 and CA125 levels in serum were determined by ELISA and ECLIA.The ratio of CCR1/HPRT mRNA in peripheral blood of patients with endometriosis and adenomyosis was significantly elevated compared with women without endometriosis. Additionally, serum levels of MCP-1 and CA125 were significantly higher in patients with endometriosis. This method showed a sensitivity of 92.2%, a specificity of 81.6%, a negative predictive value of 83.3%, a positive predictive value of 92.3%, a likelihood ratio of a positive test result of 5.017, and a likelihood ratio of a negative test result of 0.096 to predict the presence or absence of endometriosis.The results imply the potential use of CCR1 mRNA, MCP-1, and CA125 protein measurements for the diagnosis or exclusion of endometriosis.
Key Words: CA125 CCR1 mRNA diagnostic test endometriosis MCP-1.
Reproductive Sciences, Vol. 15, No. 9,
906-911 (2008) |
|
|||

